Cargando…

Clinical Features of COVID-19 Patients with Different Outcomes in Wuhan: A Retrospective Observational Study

Coronavirus disease 2019 (COVID-19) has caused considerable morbidity and mortality worldwide since December 2019. This retrospective study determined the characteristics and prognostic factors of COVID-19 patients, focusing on inpatients who died or were discharged between 30 December 2019 and 29 F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhen, Ye, Di, Wang, Menglong, Zhao, Mengmeng, Li, Dan, Ye, Jing, Liu, Jianfang, Xu, Yao, Zhang, Jishou, Pan, Wei, Liu, Menglin, Luo, Zhen, Wan, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537706/ https://www.ncbi.nlm.nih.gov/pubmed/33029494 http://dx.doi.org/10.1155/2020/2138387

Ejemplares similares

The Association between Obesity and Severity in Patients with Coronavirus Disease 2019: a Retrospective, Single-center Study, Wuhan
por: Zhang, Jishou, et al.
Publicado: (2021)

Time-dependent changes in the clinical characteristics and prognosis of hospitalized COVID-19 patients in Wuhan, China: A retrospective study
por: Wang, Menglong, et al.
Publicado: (2020)

The Clinical Characteristics and Prognosis Factors of Mild-Moderate Patients With COVID-19 in a Mobile Cabin Hospital: A Retrospective, Single-Center Study
por: Zhang, Jishou, et al.
Publicado: (2020)

Il12a Deletion Aggravates Sepsis-Induced Cardiac Dysfunction by Regulating Macrophage Polarization
por: Wang, Zhen, et al.
Publicado: (2021)

Advances in the relationship between coronavirus infection and cardiovascular diseases
por: Zhao, Mengmeng, et al.
Publicado: (2020)

The Anti-inflammatory Mediator Resolvin E1 Protects Mice Against Lipopolysaccharide-Induced Heart Injury
por: Zhang, Jishou, et al.
Publicado: (2020)

Resolvin D1 Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Inflammation, Oxidative and Endoplasmic Reticulum Stress
por: Wang, Menglong, et al.
Publicado: (2022)

The TRPA1 Channel in the Cardiovascular System: Promising Features and Challenges
por: Wang, Zhen, et al.
Publicado: (2019)

Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages
por: Zhao, Mengmeng, et al.
Publicado: (2020)

Recent progress of antiviral therapy for coronavirus disease 2019
por: Zhao, Mengmeng, et al.
Publicado: (2021)

The Role of CXC Chemokines in Cardiovascular Diseases
por: Lu, Xiyi, et al.
Publicado: (2022)

The expression of interleukin-25 increases in human coronary artery disease and is associated with the severity of coronary stenosis
por: Xu, Yao, et al.
Publicado: (2020)

Decreased Low-Density Lipoprotein Cholesterol Level Indicates Poor Prognosis of Severe and Critical COVID-19 Patients: A Retrospective, Single-Center Study
por: Zhao, Mengmeng, et al.
Publicado: (2021)

ADAMTS-5 Decreases in Coronary Arteries and Plasma from Patients with Coronary Artery Disease
por: Wang, Zhen, et al.
Publicado: (2019)

The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Wang, Menglong, et al.
Publicado: (2023)

Interleukin-12p35 deficiency enhances mitochondrial dysfunction and aggravates cardiac remodeling in aging mice
por: Ye, Jing, et al.
Publicado: (2020)

MCC950, a Selective NLRP3 Inhibitor, Attenuates Adverse Cardiac Remodeling Following Heart Failure Through Improving the Cardiometabolic Dysfunction in Obese Mice
por: Wang, Menglong, et al.
Publicado: (2022)

IL-12p40 deletion aggravates lipopolysaccharide-induced cardiac dysfunction in mice
por: Liu, Menglin, et al.
Publicado: (2022)

Inhibition of TRPA1 Attenuates Doxorubicin-Induced Acute Cardiotoxicity by Suppressing Oxidative Stress, the Inflammatory Response, and Endoplasmic Reticulum Stress
por: Wang, Zhen, et al.
Publicado: (2018)

Corrigendum to “TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice” [EBioMedicine (2018) 54–62]
por: Wang, Zhen, et al.
Publicado: (2018)

TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice
por: Wang, Zhen, et al.
Publicado: (2018)

Scavenger Receptors in Myocardial Infarction and Ischemia/Reperfusion Injury: The Potential for Disease Evaluation and Therapy
por: Zhang, Jishou, et al.
Publicado: (2023)

The Role of Interleukin-6 Family Members in Cardiovascular Diseases
por: Feng, Yongqi, et al.
Publicado: (2022)

Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice
por: Ye, Jing, et al.
Publicado: (2020)

Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges
por: Ye, Jing, et al.
Publicado: (2020)

Microglia‐Mediated Neuroimmune Response Regulates Cardiac Remodeling After Myocardial Infarction
por: Wang, Menglong, et al.
Publicado: (2023)

The Expression of IL-12 Family Members in Patients with Hypertension and Its Association with the Occurrence of Carotid Atherosclerosis
por: Ye, Jing, et al.
Publicado: (2020)

Clinical course and characteristics of patients with coronavirus disease 2019 in Wuhan, China: a single-centered, retrospective, observational study
por: Liu, Yanfang, et al.
Publicado: (2020)

Impact of ethyl pyruvate on Adriamycin-induced cardiomyopathy in rats
por: Liu, Menglin, et al.
Publicado: (2016)

IL-30 protects against sepsis-induced myocardial dysfunction by inhibiting pro-inflammatory macrophage polarization and pyroptosis
por: Zhao, Mengmeng, et al.
Publicado: (2023)

Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Cardiovascular Diseases
por: Wang, Menglong, et al.
Publicado: (2022)

Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study
por: Du, Yingzhen, et al.
Publicado: (2020)

Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure
por: Ye, Jing, et al.
Publicado: (2019)

The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future
por: Zhang, Jishou, et al.
Publicado: (2020)

CT-Based Risk Factors for Mortality of Patients With COVID-19 Pneumonia in Wuhan, China: A Retrospective Study
por: Li, Xiang, et al.
Publicado: (2021)

Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice
por: Ye, Jing, et al.
Publicado: (2017)

Erratum to “Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice”
por: Ye, Jing, et al.
Publicado: (2018)

Viral Transmission and Clinical Features in Asymptomatic Carriers of SARS-CoV-2 in Wuhan, China
por: Tan, Fen, et al.
Publicado: (2020)

Impact of COVID-19 Outbreak on the Gynecological Outpatients HPV Infection Rate in Wuhan, China: A Retrospective Observational Study
por: Liu, Hang, et al.
Publicado: (2022)

Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study
por: Sun, Dan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fmoj2tbhg1kcbpjgr4t21bkfcv